BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 26496461)

  • 1. Reference set for performance testing of pediatric vaccine safety signal detection methods and systems.
    Brauchli Pernus Y; Nan C; Verstraeten T; Pedenko M; Osokogu OU; Weibel D; Sturkenboom M; Bonhoeffer J;
    Vaccine; 2016 Dec; 34(51):6626-6633. PubMed ID: 26496461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Masking by vaccines in pediatric drug safety signal detection in the EudraVigilance database.
    Dodd C; Pacurariu A; Osokogu OU; Weibel D; Ferrajolo C; Vo DH; Becker B; Kors JA; Sturkenboom M
    Pharmacoepidemiol Drug Saf; 2018 Nov; 27(11):1249-1256. PubMed ID: 30066460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric drug safety signal detection: a new drug-event reference set for performance testing of data-mining methods and systems.
    Osokogu OU; Fregonese F; Ferrajolo C; Verhamme K; de Bie S; 't Jong G; Catapano M; Weibel D; Kaguelidou F; Bramer WM; Hsia Y; Wong IC; Gazarian M; Bonhoeffer J; Sturkenboom M
    Drug Saf; 2015 Feb; 38(2):207-17. PubMed ID: 25663078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of 'SAEFVIC', A Pharmacovigilance Surveillance Scheme for the Spontaneous Reporting of Adverse Events Following Immunisation in Victoria, Australia.
    Clothier HJ; Crawford NW; Russell M; Kelly H; Buttery JP
    Drug Saf; 2017 Jun; 40(6):483-495. PubMed ID: 28342074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A signal detection method for temporal variation of adverse effect with vaccine adverse event reporting system data.
    Cai Y; Du J; Huang J; Ellenberg SS; Hennessy S; Tao C; Chen Y
    BMC Med Inform Decis Mak; 2017 Jul; 17(Suppl 2):76. PubMed ID: 28699543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A reference standard for evaluation of methods for drug safety signal detection using electronic healthcare record databases.
    Coloma PM; Avillach P; Salvo F; Schuemie MJ; Ferrajolo C; Pariente A; Fourrier-Réglat A; Molokhia M; Patadia V; van der Lei J; Sturkenboom M; Trifirò G
    Drug Saf; 2013 Jan; 36(1):13-23. PubMed ID: 23315292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
    Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
    MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease-specific adverse events following nonlive vaccines: a paradoxical placebo effect or a nocebo phenomenon?
    Okaïs C; Gay C; Seon F; Buchaille L; Chary E; Soubeyrand B
    Vaccine; 2011 Aug; 29(37):6321-6. PubMed ID: 21627976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous reports of vasculitis as an adverse event following immunization: A descriptive analysis across three international databases.
    Felicetti P; Trotta F; Bonetto C; Santuccio C; Brauchli Pernus Y; Burgner D; Chandler R; Girolomoni G; Hadden RD; Kochhar S; Kucuku M; Monaco G; Ozen S; Pahud B; Phuong L; Bachtiar NS; Teeba A; Top K; Varricchio F; Wise RP; Zanoni G; Živkovic S; Bonhoeffer J;
    Vaccine; 2016 Dec; 34(51):6634-6640. PubMed ID: 26392009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capacity for a global vaccine safety system: the perspective of national regulatory authorities.
    Graham JE; Borda-Rodriguez A; Huzair F; Zinck E
    Vaccine; 2012 Jul; 30(33):4953-9. PubMed ID: 22658930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structured assessment for prospective identification of safety signals in electronic medical records: evaluation in the health improvement network.
    Cederholm S; Hill G; Asiimwe A; Bate A; Bhayat F; Persson Brobert G; Bergvall T; Ansell D; Star K; Norén GN
    Drug Saf; 2015 Jan; 38(1):87-100. PubMed ID: 25539877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine pharmacovigilance in India: Current context and future perspective.
    Meher BR
    Indian J Pharmacol; 2019; 51(4):243-247. PubMed ID: 31571710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective vaccine safety systems in all countries: a challenge for more equitable access to immunization.
    Amarasinghe A; Black S; Bonhoeffer J; Carvalho SM; Dodoo A; Eskola J; Larson H; Shin S; Olsson S; Balakrishnan MR; Bellah A; Lambach P; Maure C; Wood D; Zuber P; Akanmori B; Bravo P; Pombo M; Langar H; Pfeifer D; Guichard S; Diorditsa S; Hossain MS; Sato Y
    Vaccine; 2013 Apr; 31 Suppl 2():B108-14. PubMed ID: 23598471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation for global introduction of inactivated poliovirus vaccine: safety evidence from the US Vaccine Adverse Event Reporting System, 2000-12.
    Iqbal S; Shi J; Seib K; Lewis P; Moro PL; Woo EJ; Shimabukuro T; Orenstein WA
    Lancet Infect Dis; 2015 Oct; 15(10):1175-1182. PubMed ID: 26289956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of regulation changes in the spontaneous reporting system for vaccines on reporting trends and signal detection in Japan.
    Miyazaki M; Sakai T; Obara T; Mano N
    Pharmacoepidemiol Drug Saf; 2021 Aug; 30(8):1091-1100. PubMed ID: 33733540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatal outcomes following immunization errors as reported to the EudraVigilance: A case series.
    Hoeve CE; Gadroen K; Kwa MSG; van Haren A; Sturkenboom MCJM; Straus SMJM
    Vaccine; 2020 Mar; 38(15):3086-3095. PubMed ID: 32147297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges in evaluating post-licensure vaccine safety: observations from the Centers for Disease Control and Prevention.
    Moro PL; Haber P; McNeil MM
    Expert Rev Vaccines; 2019 Oct; 18(10):1091-1101. PubMed ID: 31580725
    [No Abstract]   [Full Text] [Related]  

  • 18. Useful Interplay Between Spontaneous ADR Reports and Electronic Healthcare Records in Signal Detection.
    Pacurariu AC; Straus SM; Trifirò G; Schuemie MJ; Gini R; Herings R; Mazzaglia G; Picelli G; Scotti L; Pedersen L; Arlett P; van der Lei J; Sturkenboom MC; Coloma PM
    Drug Saf; 2015 Dec; 38(12):1201-10. PubMed ID: 26370104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of statistical signal detection methods within and across spontaneous reporting databases.
    Candore G; Juhlin K; Manlik K; Thakrar B; Quarcoo N; Seabroke S; Wisniewski A; Slattery J
    Drug Saf; 2015 Jun; 38(6):577-87. PubMed ID: 25899605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Causality assessment of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS).
    Loughlin AM; Marchant CD; Adams W; Barnett E; Baxter R; Black S; Casey C; Dekker C; Edwards KM; Klein J; Klein NP; LaRussa P; Sparks R; Jakob K
    Vaccine; 2012 Nov; 30(50):7253-9. PubMed ID: 23063829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.